The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Access to fertility preservation services among commercially insured adults with early-onset colorectal cancer.
 
Zoe Finer
No Relationships to Disclose
 
Youngmin Kwon
No Relationships to Disclose
 
Kristen Ciombor
Consulting or Advisory Role - Agenus; ALX Oncology; Bayer; BeiGene; Exact Sciences; Exelixis; Incyte; Merck; Pfizer; Summit Therapeutics; Taiho Oncology; Tempus
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst); Seagen (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Incyte; Tempus
 
Alexandra Sundermann
Employment - Vanderbilt University Medical Center
 
Michelle Roach
No Relationships to Disclose
 
Raha Al-Marzooqi
No Relationships to Disclose
 
Digna Velez Edwards
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Agenus; ALX Oncology; amplia; Astellas Pharma; BeiGene; Bristol-Myers Squibb/Celgene; epsilon; insmed; ipsen; Mekanistic Therapeutics; Merck KGaA; Regeneron; Taiho Oncology
Research Funding - 23andMe (Inst); Abbvie (Inst); Astellas Pharma (Inst); Atreca (Inst); Bayer (Inst); Bristol-Myers Squibb/Celgene (Inst); Bristol-Myers Squibb/Celgene (Inst); clasp (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); I-MAB (Inst); Incendia Pharmaceuticals AB (Inst); Incyte (Inst); Lilly (Inst); Nested Therapeutics (Inst); ribosciences (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Totus Medicines (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck KGaA
Other Relationship - AstraZeneca; Boehringer Ingelheim; novocure
 
Cathy Eng
Consulting or Advisory Role - Abbvie; Abbvie; Agenus; Amgen (I); Boehringer Ingelheim; Bristol Myers Squibb Foundation; EMD Serono; Gilead Sciences; GlaxoSmithKline; Incyte; Merck; Merus; Pfizer; Revolution Medicines; Taiho Oncology (I); Takeda
Research Funding - Gritstone Bio (Inst); Hutchison MediPharma (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Takeda
 
Richard Goldberg
Employment - Agenus
Stock and Other Ownership Interests - Advanced Chemotherapy Technologies; Compass Therapeutics; Quest Diagnostics
Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Bayer; Compass Therapeutics; Eisai/H3 Biomedicine; Focal Medical, inc; G1 Therapeutics; GeneCentric; Haystack Oncology; Innovative Cellular Therapeutics Co; Inspira; IQvia; Merck; Modulation Therapeutics; RIN Institute; Sorrento Therapeutics; Taiho Pharmaceutical; Takeda; UpToDate; Valar Labs
Expert Testimony - Johns Hopkins Hospital; Taiho Pharmaceutical
 
Ashley Leech
No Relationships to Disclose
 
Stacie Dusetzina
Other Relationship - Arnold Ventures (Inst); Institute for Clinical and Economic Review; Leukemia and Lymphoma Society (Inst); Medicare Payment Advisory Commission; The Commonwealth Fund (Inst)
 
Andreana Holowatyj
Consulting or Advisory Role - Bayer; MJH Life Sciences
Research Funding - Pfizer
(OPTIONAL) Uncompensated Relationships - Appendix Cancer PMP Research Foundation